This study is a post-market, multicentre, prospective, single arm investigation aimed to systematically collect safety and performance data on the Sentio system, when used as intended for adolescents (12-17 years inclusive).
Protocol Amendment History
2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-02-19; most recent amendment 2025-09-17.
Status change: Not Yet Recruiting → Recruiting2025-09-17